Clinical characteristics and outcomes after 5 years pro re nata treatment of neovascular age‐related macular degeneration with ranibizumab

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Access to Document

@article{ba7666486e7c4fa6ae55b36f83699b5e,

title = "Clinical characteristics and outcomes after 5 years pro re nata treatment of neovascular age‐related macular degeneration with ranibizumab",

author = "Archana Airody and Divya Venugopal and Victoria Allgar and Gale, \{Richard P.\}",

year = "2015",

month = sep,

doi = "10.1111/aos.12618",

language = "English",

volume = "93",

journal = "Acta Ophthalmologica",

issn = "1755-375X",

publisher = "John Wiley and Sons Inc.",

number = "6",

}

TY - JOUR

T1 - Clinical characteristics and outcomes after 5 years pro re nata treatment of neovascular age‐related macular degeneration with ranibizumab

AU - Airody, Archana

AU - Venugopal, Divya

AU - Allgar, Victoria

AU - Gale, Richard P.

PY - 2015/9

Y1 - 2015/9

U2 - 10.1111/aos.12618

DO - 10.1111/aos.12618

M3 - Article

SN - 1755-375X

VL - 93

JO - Acta Ophthalmologica

JF - Acta Ophthalmologica

IS - 6

ER -